Skip to main content

Going Public Through a Non-Traditional IPO


Date: May 9, 2017

Time: 3:30AM - 5:30AM

Location: San Diego, CA

Mintz Levin is hosting a three-part series focused on financing for life sciences companies from initial funding to IPO via private sources, non-traditional IPO's, and traditional IPO's.

In part two of the series, we will focus on Going Public Through a Non-Traditional IPO. Initial Public Offerings are a great way to raise money for your life sciences business. However doing a traditional IPO may be difficult for some earlier stage companies and even seasoned companies in a difficult IPO market. At this program we will discuss alternative ways to raise money in the public markets and create liquidity for you and your investors that may be more suitable for earlier stage life science companies. Come hear our panel explain your options and show you how to maximize your opportunity for a successful transaction.


Jeremy D. Glaser is Co-chair of Mintz's Venture Capital & Emerging Companies Practice. He has over three decades of experience guiding life sciences and technology companies in growth and financing strategies, including public offerings, financings, mergers and acquisitions, and SEC compliance.
Professional Cropped Hicks William Mintz

William C. Hicks


William C. Hicks is Co-chair of the Securities & Capital Markets Practice Group at Mintz. Bill provides a variety of services for his clients, including executing IPOs, cross-over investments, alternative public offerings, CMPOs, registered directs, PIPEs, and private placements.